Icons / Logo / Facebook Created with Sketch. Icons / Logo / Google Created with Sketch. Icons / Logo / ORCID Created with Sketch. Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch. Match!
Cheng-Tao Chang
Publications 6
Published on Sep 1, 2017in International Clinical Psychopharmacology 1.64
Michael E. Thase112
Estimated H-index: 112
John Edwards3
Estimated H-index: 3
+ 4 AuthorsCarl Gommoll12
Estimated H-index: 12
Abstract Treatment-emergent suicidal ideation and behavior are ongoing concerns with antidepressants. Vilazodone, currently approved for the treatment of major depressive disorder (MDD) in adults, has also been evaluated in generalized anxiety disorder (GAD). Post-hoc analyses of vilazodone trials were carried out to examine its effects on suicidal ideation and behavior in adults with MDD or GAD. Data were pooled from vilazodone trials in MDD (four studies) and GAD (three studies). The incidence...
Published on Mar 1, 2017in Schizophrenia Bulletin 7.29
Jelena Kunovac , John M. Kane102
Estimated H-index: 102
+ 4 AuthorsWillie Earley13
Estimated H-index: 13
Abstract Background: Relapse is common in schizophrenia; identifying characteristics associated with relapse may help improve disease management. Cariprazine, a D3/D2 receptor partial agonist, is approved in the United States for the treatment of schizophrenia. Post hoc analyses of a long-term, randomized, double-blind (up to 72 weeks), relapse prevention trial (NCT01412060) were performed to identify characteristics associated with relapse in placebo- and cariprazine-treated patients. Methods: ...
Published on Mar 1, 2017in Schizophrenia Bulletin 7.29
Steven G. Potkin80
Estimated H-index: 80
(UCI: University of California, Irvine),
Christoph U. Correll59
Estimated H-index: 59
+ 3 AuthorsWillie Earley13
Estimated H-index: 13